Cargando…
Effects of amyloid precursor protein peptide APP96-110, alone or with human mesenchymal stromal cells, on recovery after spinal cord injury
Delivery of a peptide (APP96-110), derived from amyloid precursor protein (APP), has been shown to elicit neuroprotective effects following cerebral stroke and traumatic brain injury. In this study, the effect of APP96-110 or a mutant version of this peptide (mAPP96-110) was assessed following moder...
Autores principales: | Hodgetts, Stuart I., Lovett, Sarah J., Baron-Heeris, D., Fogliani, A., Sturm, Marian, den Heuvel, C. Van, Harvey, Alan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643048/ https://www.ncbi.nlm.nih.gov/pubmed/34782585 http://dx.doi.org/10.4103/1673-5374.327357 |
Ejemplares similares
-
The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury
por: Plummer, Stephanie L., et al.
Publicado: (2018) -
Cortical AAV-CNTF Gene Therapy Combined with Intraspinal Mesenchymal Precursor Cell Transplantation Promotes Functional and Morphological Outcomes after Spinal Cord Injury in Adult Rats
por: Hodgetts, Stuart I., et al.
Publicado: (2018) -
Assessment of R18, COG1410, and APP96-110 in Excitotoxicity and Traumatic Brain Injury
por: Chiu, Li Shan, et al.
Publicado: (2017) -
Amyloid Precursor Protein (APP) and GABAergic Neurotransmission
por: Tang, Bor Luen
Publicado: (2019) -
β-Amyloid precursor protein (APP) and the human diseases
por: Nguyen, Khue Vu
Publicado: (2019)